• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

HAEMONETICS CORPORATION

Notes

No. Proposition For Against Abstain
1

Election of Director: Robert E. Abernathy

2

Election of Director: Diane M. Bryant

3

Election of Director: Michael J. Coyle

4

Election of Director: Lloyd E. Johnson

5

Election of Director: Mark W. Kroll

6

Election of Director: Claire Pomeroy

7

Election of Director: Christopher A. Simon

8

Election of Director: Ellen M. Zane

9

To approve, on an advisory basis, the compensation of our named executive officers.

10

To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 3, 2027.

11

To approve an amendment and restatement of the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan.

12

To approve an amendment and restatement of the Haemonetics Corporation Amended and Restated 2007 Employee Stock Purchase Plan.